Dr. Michael S. Korenfeld, MD

Dr. Korenfeld practices at Comprehensive Eye Care, Ltd. in Washington, Missouri.

Dr. Korenfeld's NPI, 1174515613, was assigned on August 19, 2005. Dr. Korenfeld graduated from Washington University School of Medicine in 1986. Dr. Korenfeld holds Missouri license R1P88.

Dr. Korenfeld's primary practice is Comprehensive Eye Care, Ltd., at 901 E 3rd St, Washington, MO 63090 in Franklin County. The practice phone is (636) 390-3999.

Dr. Korenfeld's primary practice is Comprehensive Eye Care, Ltd. in Washington, Missouri. Dr. Korenfeld is also affiliated with Mercy Hospital Washington. Dmand AI also links Dr. Korenfeld to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Korenfeld practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Korenfeld's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Korenfeld is licensed in Missouri.

CMS data shows 1,028 Medicare services from Dr. Korenfeld across 14 procedure codes in 2024, for 478 Medicare patients. Medicare paid $91,340 for them.

CMS counts 478 Medicare patients who saw Dr. Korenfeld in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Korenfeld's median patient age at 69, with 57% women.

In 2024, Dr. Korenfeld wrote 1,935 Medicare Part D claims for 635 patients. 53% of them were for generic drugs. CMS names the drug for 1,786 of them, across 26 drugs with 11 or more claims each, at $177,512 in total drug cost. In 2023, CMS named 1,707 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Korenfeld for performance year 2024, reported as part of a group. Dr. Korenfeld accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 182 procedures of cataract surgery by Dr. Korenfeld, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Korenfeld, published from 2011 to 2023. 2016 was the busiest year, with 3. The most frequent topics are Ophthalmic Solutions, Double-Blind Method and Dexamethasone. Dr. Korenfeld has published most often in Clin Ophthalmol. Dr. Korenfeld's most frequent co-authors are Jason Bacharach, MD, Damien Forrest Goldberg, MD and Joseph R. Martel, MD.

Dmand AI links Dr. Korenfeld to 6 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Cataract, Lens Diseases and Dry Eye Syndromes. Kala Pharmaceuticals, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Korenfeld that name 1 trial.

CMS Open Payments shows 61 general payments to Dr. Korenfeld from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. EyePoint Pharmaceuticals US, Inc. paid the most, $27,380. It also lists 5 research payments totaling $40,970 from 2018 to 2019, naming 1 clinical trial.

Dr. Korenfeld graduated from Washington University School of Medicine in 1986.